CD276 as a promising diagnostic and prognostic biomarker for bladder cancer through bioinformatics and clinical research

CD276 as a promising diagnostic and prognostic biomarker for bladder cancer through bioinformatics and clinical research

ObjectiveTo assess CD276 expression and explore its relationship with the clinicopathological characteristics and prognosis of patients with bladder cancer.MethodsIn total, RNA-sequencing data and clinical profiles of 436 bladder cancer cases from The Cancer Genome Atlas (TCGA) were assessed using t...

Full description

Bibliographic Details
Main Authors: Qi Zhou, Jianhao Xu, Xuelei Chen, Jun Ouyang, Caiping Mao, Zhiyu Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-09-01
Series:Frontiers in Oncology
Subjects:
CD276 expression
bladder cancer
prognosis
immunohistochemistry
bioinformatics database
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1445526/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1445526/full

Similar Items